Walleye Capital LLC acquired a new stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 384,021 shares of the health services provider’s stock, valued at approximately $20,645,000. Walleye Capital LLC owned approximately 0.73% of Maximus at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its position in Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Maximus by 13.4% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after acquiring an additional 150 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Maximus by 14.6% in the 1st quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider’s stock worth $85,000 after acquiring an additional 168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. Finally, Larson Financial Group LLC boosted its stake in shares of Maximus by 13.8% in the 3rd quarter. Larson Financial Group LLC now owns 1,869 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 227 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.
Wall Street Analyst Weigh In
MMS has been the topic of several recent research reports. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Zacks Research lowered shares of Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Maximus currently has a consensus rating of “Reduce”.
Maximus Price Performance
Shares of Maximus stock opened at $55.24 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. Maximus, Inc. has a one year low of $52.73 and a one year high of $100.00. The business’s 50 day simple moving average is $58.05 and its two-hundred day simple moving average is $65.96. The stock has a market capitalization of $2.89 billion, a P/E ratio of 8.16 and a beta of 0.59.
Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the firm posted $2.16 earnings per share. The business’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Analysts forecast that Maximus, Inc. will post 8.01 EPS for the current year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, August 14th. Maximus’s dividend payout ratio is currently 19.50%.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
